Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dyslipidaemia' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sharma, MD; Pavlik, VN
      Dyslipidaemia in African Americans, Hispanics and Whites with type 2 diabetes mellitus and hypertension

      DIABETES OBESITY & METABOLISM
    2. Reaven, GM
      Insulin resistance: why is it important to treat?

      DIABETES & METABOLISM
    3. Papadakis, JA; Milionis, HJ; Press, M; Mikhailidis, DP
      Treating dyslipidaemia in non-insulin-dependent diabetes mellitus - a special reference to statins

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    4. Vergis, EN; Paterson, DL; Wagener, MM; Swindells, S; Singh, N
      Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    5. Groop, L; Orho-Melander, M
      The dysmetabolic syndrome

      JOURNAL OF INTERNAL MEDICINE
    6. Misra, A; Sharma, R; Pandey, RM; Khanna, N
      Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India

      EUROPEAN JOURNAL OF CLINICAL NUTRITION
    7. Hoffmann, IS; Jimenez, E; Cubeddu, LX
      Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure

      JOURNAL OF HUMAN HYPERTENSION
    8. Dogra, G; Ward, N; Croft, KD; Mori, TA; Barrett, PHR; Herrmann, SE; Irish, AB; Watts, GF
      Oxidant stress in nephrotic syndrome: comparison of F-2-isprostanes and plasma antioxidant potential

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    9. Hjelmesaeth, J; Hartmann, A; Midtvedt, K; Aakhus, S; Stenstrom, J; Morkrid, L; Egeland, T; Tordarson, H; Fauchald, P
      Metabolic cardiovascular syndrome after renal transplantation

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    10. Locatelli, F; Bommer, J; London, GM; Martin-Malo, A; Wanners, C; Yaqoob, M; Zoccali, C
      Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    11. Snehalatha, C; Ramachandran, A; Saltyamurthy, I; Satyavani, K; Sivasankari, S; Misra, J; Viswanathan, V
      Association of proinsulin and insulin resistance with coronary artery disease in non-diabetic south Indian men

      DIABETIC MEDICINE
    12. Ismail, IS; Nazaimoon, W; Mohamad, W; Letchuman, R; Singaraveloo, M; Hew, FL; Shuguna, C; Khalid, BAK
      Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia

      DIABETIC MEDICINE
    13. Whitelaw, DC; O'Kane, M; Wales, JK; Barth, JH
      Risk factors for coronary heart disease in obese non-diabetic subjects

      INTERNATIONAL JOURNAL OF OBESITY
    14. Anderson, PJ; Critchley, JAJH; Chan, JCN; Cockram, CS; Lee, ZSK; Thomas, GN; Tomlinson, B
      Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality

      INTERNATIONAL JOURNAL OF OBESITY
    15. Berber, A; Gomez-Santos, R; Fanghanel, G; Sanchez-Reyes, L
      Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population

      INTERNATIONAL JOURNAL OF OBESITY
    16. Watanabe, TK; Okuno, S; Ono, T; Yamasaki, Y; Oga, K; Mizoguchi-Miyakita, A; Miyao, H; Suzuki, M; Momota, H; Goto, Y; Shinomiya, H; Hishigaki, H; Hayashi, I; Asai, T; Wakitani, S; Takagi, T; Nakamura, Y; Tanigami, A
      Single-allele correction of the Dmo1 locus in congenic animals substantially attenuates obesity, dyslipidaemia and diabetes phenotypes of the OLETF rat

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    17. Hammarsten, J; Hogstedt, B
      Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia

      EUROPEAN UROLOGY
    18. Pernerstorfer-Schoen, H; Jilma, B; Perschler, A; Wichlas, S; Schindler, K; Schindl, A; Rieger, A; Wagner, OF; Quehenberger, P
      Sex differences in HAART-associated dyslipidaemia

      AIDS
    19. Lindholm, EM; Palmer, AM; Graham, A
      Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages

      BIOCHEMICAL JOURNAL
    20. Tan, CE; Chew, LS; Chio, LF; Tai, ES; Lim, HS; Lim, SC; Jayakumar, L; Eng, HK; Packard, CJ
      Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetesmellitus subjects with good glycaemic control

      DIABETES RESEARCH AND CLINICAL PRACTICE
    21. Kong, C; Nimmo, L; Elatrozy, T; Anyaoku, V; Hughes, C; Robinson, S; Richmond, W; Elkeles, RS
      Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes

      ATHEROSCLEROSIS
    22. Pinizzotto, M; Castillo, E; Fiaux, M; Temler, E; Gaillard, RC; Ruiz, J
      Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes

      DIABETOLOGIA
    23. Brady, AJ
      Cardiovascular risk management in clinical practice - Role of lifestyle, hypertension, diabetes and dyslipidaemia

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    24. Betteridge, DJ
      Diabetic dyslipidaemia

      DIABETES OBESITY & METABOLISM
    25. Krempf, M; Rohmer, V; Farnier, M; Issa-Sayegh, M; Corda, C; Sirugue, I; Gerlinger, C; Masseyeff-Elbaz, MF
      Efficacy and safety of micronised fenofibrate in a randomised double-blindstudy comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia

      DIABETES & METABOLISM
    26. Luyckx, FH; Lefebvre, PJ; Scheen, AJ
      Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss

      DIABETES & METABOLISM
    27. Hvizdos, KM; Goa, KL
      Management of dyslipidaemias - The role of simvastatin

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    28. Stern, N; Grosskopf, I; Shapira, I; Kisch, E; Isaacov, A; Limor, R; Baz, M; Leshem, Y; Flatau, E; Miller, A; Greenman, Y
      Risk factor clustering in hypertensive patients: impact of the reports of NCEP-II and second joint task force on coronary prevention on JNC-VI guidelines

      JOURNAL OF INTERNAL MEDICINE
    29. Gavish, D; Leibovitz, E; Shapira, I; Rubinstein, A
      Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety

      JOURNAL OF INTERNAL MEDICINE
    30. Reaven, GM
      Insulin resistance - how important is it to treat?

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    31. Hufnagel, G; Michel, C; Vrtovsnik, F; Queffeulou, G; Kossari, N; Mignon, F
      Effects of atorvastatin on dyslipidaemia in uraemic patients on peritonealdialysis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    32. Klannemark, M; Suurinkeroinen, L; Orho-Melander, M; Groop, L; Taskinen, MR
      Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus

      DIABETIC MEDICINE
    33. Thomas, GN; Tomlinson, B; Chan, JCN; Young, RP; Critchley, JAJH
      The Trp64Arg polymorphism of the beta(3)-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome

      INTERNATIONAL JOURNAL OF OBESITY
    34. Marques-Vidal, P; Arveiler, D; Evans, A; Montaye, M; Ruidavets, JB; Haas, B; Yarnell, J; Bingham, A; Ferrieres, J; Amouyel, P; Ducimetiere, P
      Characteristics of male vitamin supplement users aged 50-59 years in France and Northern Ireland: the prime study

      INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
    35. Milionis, HJ; Elisaf, MS
      Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: Case histories

      CURRENT MEDICAL RESEARCH AND OPINION
    36. Milionis, HJ; Elisaf, MS; Mikhailidis, DP
      Treatment of dyslipidaemias in patients with established vascular disease:A revival of the fibrates

      CURRENT MEDICAL RESEARCH AND OPINION
    37. Svartvik, L; Lidfeldt, J; Nerbrand, C; Samsioe, G; Schersten, B; Nilsson, PM
      Dyslipidaemia and impaired well-being in middle-aged women reporting low Sense of Coherence - The Women's Health in the Lund Area (WHLA) Study

      SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
    38. Berrada, Y; Settaf, A; Baddouri, K; Cherrah, A; Hassar, M
      Experimental assessment of antihypertensive and hypolipidemic effects of oil of Argan, Argania sideroxylon

      THERAPIE
    39. Henzen, C; Hodel, T; Lehmann, B; Mosimann, T; Horler, U; Joss, R
      Prevalence and therapy of cardiovascular risk factors in hospitalised type2 diabetics

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    40. Noseda, G; Darioli, R; Keller, U; Mordasini, R; Shokry, A; Schaffhauser, B; Riesen, W
      Efficacy and tolerance of atorvastatin in hyperlipidaemia in private practice

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    41. Flavell, DM; Torra, IP; Jamshidi, Y; Evans, D; Diamond, JR; Elkeles, RS; Bujac, SR; Miller, G; Talmud, PJ; Staels, B; Humphries, SE
      Variation in the PPAR alpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

      DIABETOLOGIA
    42. Groop, L
      Genetics of the metabolic syndrome

      BRITISH JOURNAL OF NUTRITION
    43. Sveger, T; Flodmark, CE; Nordborg, K; Nilsson-Ehle, P; Borgfors, N
      Hereditary dyslipidaemias and combined risk factors in children with a family history of premature coronary artery disease

      ARCHIVES OF DISEASE IN CHILDHOOD
    44. Lynch, J; Wang, XL; Wilcken, DEL
      Body mass index in Australian children: recent changes and relevance of ethnicity

      ARCHIVES OF DISEASE IN CHILDHOOD
    45. Vigouroux, C; Gharakhanian, S; Salhi, Y; Nguyen, TH; Adda, N; Rozenbaum, W; Capeau, J
      Adverse metabolic disorders during highly active antiretroviral treatments(HAART) of HIV disease

      DIABETES & METABOLISM
    46. Abdel-Gayoum, AA; El-Jenjan, KB; Ghwarsha, KA
      Hyperlipidaemia in cisplatin-induced nephrotic rats

      HUMAN & EXPERIMENTAL TOXICOLOGY
    47. Betteridge, DJ
      Diabetic dyslipidaemias

      ACTA DIABETOLOGICA
    48. Haffner, SM
      Evaluating the status of diabetes as a risk factor for coronary artery disease

      ACTA DIABETOLOGICA
    49. Taskinen, MR
      Strategies to treat CHD risk factors in type 2 diabetic patients

      ACTA DIABETOLOGICA
    50. Best, JD
      The role of atorvastatin in type 2 diabetic patients

      ACTA DIABETOLOGICA
    51. Lepre, F; Rigby, R; Hawley, C; Saltissi, D; Brown, A; Walsh, ZA
      A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients

      CLINICAL TRANSPLANTATION
    52. Hammarsten, J; Hogstedt, B
      Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia

      BLOOD PRESSURE
    53. DiMartino-Nardi, J
      Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls

      ACTA PAEDIATRICA
    54. Vanhala, M
      Childhood weight and metabolic syndrome in adults

      ANNALS OF MEDICINE
    55. Bjorntorp, P; Holm, G; Rosmond, R
      Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus

      DIABETIC MEDICINE
    56. Stewart, R; Liolitsa, D
      Type 2 diabetes mellitus, cognitive impairment and dementia

      DIABETIC MEDICINE
    57. Velussi, M; Cernigoi, AM; Tortul, C; Merni, M
      Atorvastatin for the management of Type 2 diabetic patients with dyslipidaemia. A mid-term (9 months) treatment experience

      DIABETES NUTRITION & METABOLISM
    58. Tiras, MB; Yalcin, R; Noyan, V; Maral, I; Yildirim, M; Dortlemez, O; Daya, S
      Alterations in cardiac flow parameters in patients with polycystic ovariansyndrome

      HUMAN REPRODUCTION
    59. Bennani-Kabchi, N; El Bouayadi, F; Kehel, L; Fdhil, H; Marquie, G
      Effect of Suaeda fruticosa aqueous extract in the hypercholesterolaemic and insulin-resistant sand rat

      THERAPIE
    60. Betteridge, DJ
      Diabetic dyslipidaemia

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    61. Shaw, JTE; Purdie, DM; Neil, HAW; Levy, JC; Turner, RC
      The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus

      DIABETOLOGIA
    62. Best, JD; O'Neal, D; Kamarudin, N; Alford, FP; Best, JD
      Growth hormone deficiency and cardiovascular risk

      BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM
    63. Klannemark, M; Orho, M; Langin, D; Laurell, H; Holm, C; Reynisdottir, S; Arner, P; Groop, L
      The putative role of the hormone-sensitive lipase gene in the pathogenesisof Type II diabetes mellitus and abdominal obesity

      DIABETOLOGIA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 11:38:44